The Shelf
Contributions
Help make Wikinvest better! Learn how to get involved. And create an account to build your reputation.
Did you know…?
Bookmarks
close
Edit Metric
Company
Value
Source
Source URL
Notes
Cancel
 
close
Edit  |  History
Details
Company:
Value :
Source:
Source URL:
Notes:
 

ev3 (EVVV), headquartered in Plymouth Minnesota, went public on June 21, 2005. The company concentrates on catheter-based, or endovascular, technologies for the minimally invasive treatment of vascular diseases and disorders. The company's acquired broad product portfolio is focused, hence its corporate name, on applications in each of the three sub-markets of the endovascular device market: peripheral vascular, cardiovascular and neurovascular. The company develops, manufactures, and markets an extensive variety of products like stents, embolic protection devices, thrombectomy devices, balloon angioplasty catheters, retrieval devices, guidewires, embolic coils, liquid embolics, microcatheters, and occlusion balloon systems. The company operates in principally two product segments: cardio peripheral and neurovascular. The cardio peripheral segment consists of products that are used by cardiologists, radiologists, vascular surgeons, and other specialists in both cardiovascular and peripheral vascular procedures. The products in the segment include stents, thrombectomy devices, and embolic protection devices, and procedural support devices and others. The neurovascular division, principally Micro Therapeutics, includes products that are used primarily by neuro-radiologists and neurosurgeons for neurovascular procedures. This segment comprises embolic products, and neuro access and delivery products. The company completed the acquisition of all of the outstanding shares of Micro Therapeutics that it did not already own on January 6, 2006. In October 2007, ev3 Inc. and FoxHollow Technologies, Inc. completed their merger whereby EVVV acquired all the outstanding shares of FoxHollow common stock, resulting in FoxHollow becoming a wholly owned subsidiary of ev3.

The company's combined product portfolio will include a broad array of products to treat vascular disease in both the peripheral and neurovascular markets, including atherectomy and thrombectomy, PTA balloons, stents, embolic protection devices, infusion catheters/wires, embolic coils and liquid embolics.

The combined company's ownership composition consisted of approximately 41% from FoxHollow stockholders and 59% from ev3 stockholders.

The company sells over 100 products in more than 50 countries. Operating a direct sales force in the United States, Europe, Canada, and Japan, ev3 markets through distributors in other international markets. For 2007, U.S. revenues represented 62% of total revenues, with international revenues contributing 38%.



[edit] References

Worried about pump and dump?
We review changes
for stock spam
Want to make Wikinvest better?
We need your help,
contribute today
Do you write software?
We are recruiting
the best engineers
Like Wikinvest?
Spread the word —
Tell your friends!
Wikinvest © 2006, 2007, 2008. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki